Related Articles
Prognostic and predictive value of CEA and CYFRA 21-1 levels in advanced non-small cell lung cancer patients treated with gefitinib or erlotinib
Changes in serum thymidine kinase 1 levels during chemotherapy correlate with objective response in patients with advanced gastric cancer
First-line single-agent chemotherapy for patients with recurrent or metastatic gastric cancer with poor performance status
Efficacy analysis of immunotherapy‑based combinations for patients with EGFR‑mutant advanced non‑small cell lung cancer after TKI failure
Vinflunine treatment in patients with metastatic urothelial cancer: A Nordic retrospective multicenter analysis Corrigendum in /10.3892/ol.2017.6082